Adaptimmune Therapeutics PLC ADR Stock
There is an upward development for Adaptimmune Therapeutics PLC ADR compared to yesterday, with an increase of €0.010 (1.050%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Adaptimmune Therapeutics PLC ADR stock is not clear.
With a target price of 1 € there is a slightly positive potential of 4.17% for Adaptimmune Therapeutics PLC ADR compared to the current price of 0.96 €.
Our community identified positive and negative aspects for Adaptimmune Therapeutics PLC ADR stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adaptimmune Therapeutics PLC ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adaptimmune Therapeutics PLC ADR in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adaptimmune Therapeutics PLC ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC ADR | 1.050% | 1.064% | -8.654% | -5.941% | 52.000% | -75.641% | - |
Tissue Regenix Group Plc | - | 4.828% | 10.949% | 35.352% | 34.513% | - | - |
Cicassia Pharmaceuticals | -1.280% | -1.887% | 4.000% | 14.706% | 11.429% | 98.980% | 284.236% |
Optibiotix Health plc | -2.030% | -4.369% | -4.369% | 115.301% | -32.993% | -65.739% | - |